After Supreme Court Patent Ruling, Availability of Gene Tests Could Broaden

Posted by Kendall Harmon

Almost immediately after the Supreme Court ruled that human genes could not be patented, several laboratories announced they, too, would begin offering genetic testing for breast cancer risk, making it likely that that test and others could become more affordable and more widely available.

The ruling in effect ends a nearly two-decade monopoly by Myriad Genetics, the company at the center of the case.

“It levels the playing field; we can all go out and compete,” said Sherri Bale, managing director of GeneDx, a testing company, which plans to offer a test for breast cancer risk. “This is going to make a lot more genetic tests available, especially for rare diseases.”

Read it all.

Filed under: * Culture-WatchHealth & MedicineLaw & Legal IssuesScience & Technology* Economics, PoliticsEconomyConsumer/consumer spendingCorporations/Corporate Life* TheologyAnthropologyEthics / Moral Theology

0 Comments
Posted June 14, 2013 at 8:00 am [Printer Friendly] [Print w/ comments]
Registered members must log in to comment.




Next entry (above): David Brooks—Religion and Inequality

Previous entry (below): Charleston, South Carolina,  restaurants brace for Affordable Care Act

Return to blog homepage

Return to Mobile view (headlines)